• Skip to primary navigation
  • Skip to main content
  • Skip to footer
ElevateBio

ElevateBio

Powering the creation of cell & gene therapies at a speed the world deserves.

  • Investors & Media
    • Investors & Media Overview
    • Press Releases
    • Posters & Publications
    • Elevated Insights
  • Careers
  • Locations
  • Contact
  • Search
  • Manufacturing & Development Services
    • End-to-End Capabilities Overview
    • cGMP Manufacturing and Automation
    • Process Development
    • Analytical Development
    • Next-Generation Sequencing
    • Quality
    • Regulatory CMC
    • ElevateBio BaseCamp Certifications and Compliance
    • Modalities Powered by ElevateBio
  • Gene Editing Technologies and R&D
    • Technology Platforms Overview
    • Technology Platform
    • Therapeutic Applications
    • AI & Protein Engineering
  • Genetic Medicines
  • Partnering
  • About
    • About Overview
    • How We Work
    • Our Team
    • Culture of Expedition
    • Careers
  • Investors & Media
    • Investors & Media Overview
    • Press Releases
    • Posters & Publications
    • Elevated Insights
  • Careers
  • Locations
  • Contact
  • Manufacturing & Development Services basecamp

    Basecamp
    Manufacturing & Development Services Overview

    Capabilities & Services
    • cGMP Manufacturing and Automation
    • Process Development
    • Analytical Development
    • Next-Generation Sequencing
    Expertise
    • Quality
    • Regulatory CMC
    • BaseCamp Certifications and Compliance
    • Modalities Powered by ElevateBio
  • Gene Editing Technologies and R&D life edit

    Life Edit
    Gene Editing Technologies and R&D Overview

    • Technology Platform
    • Therapeutic Applications
    • AI & Protein Engineering
  • Genetic Medicines
  • Partnering
  • About
    • About Overview
    • How We Work
    • Our Team
    • Culture of Expedition
    • Careers
Home / Investors & Media / Posters & Presentations / Signature of Base Editor RNA Edits in the Transcriptome and Reduction of Exogenous RNA Editing

// May 14, 2025 | American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting New Orleans, LA

Signature of Base Editor RNA Edits in the Transcriptome and Reduction of Exogenous RNA Editing

Footer

ElevateBio

Investors & Media

LinkedIn Twitter

© 2025 ElevateBio. All Rights Reserved.

Privacy & Cookie Policy

  • Manufacturing & Development Services basecamp
  • Gene Editing Technologies and R&D life edit
  • Genetic Medicines
  • Partnering
  • About
  • Posters & Publications
  • Elevated Insights
  • Careers
  • Locations
  • Contact
MENU
  • Manufacturing & Development Services
    • End-to-End Capabilities Overview
    • cGMP Manufacturing and Automation
    • Process Development
    • Analytical Development
    • Next-Generation Sequencing
    • Quality
    • Regulatory CMC
    • ElevateBio BaseCamp Certifications and Compliance
    • Modalities Powered by ElevateBio
  • Gene Editing Technologies and R&D
    • Technology Platforms Overview
    • Technology Platform
    • Therapeutic Applications
    • AI & Protein Engineering
  • Genetic Medicines
  • Partnering
  • About
    • About Overview
    • How We Work
    • Our Team
    • Culture of Expedition
    • Careers
  • Investors & Media
    • Investors & Media Overview
    • Press Releases
    • Posters & Publications
    • Elevated Insights
  • Careers
  • Locations
  • Contact